A critical breakthrough in cancer research is arising with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in various kinds of cancer, causing https://top100bookmark.com/story22126279/mini-antibodies-reactivate-the-p53-protein-new-potential-approach-for-tumor-therapy